What
Where
NEW AWARD FOR ATROPINE/DIPHENOXYLATE HCL TABLETS WITH SPECGX, LLC . PERIOD OF PERFORMANCE IS MAY 27, 2023 THROUGH MAY 26, 2024 WITH FOUR ONE YEAR OPTION YEARS.
From: Federal Procurement Data System(Federal)
 Basic Details |  Start Date27 May, 2023 (11 months ago) Due Date26 May, 2024 (in 27 days) TypeContractIdentifier36E79723R0005 | ||||
 Customer / Agency | VETERANS AFFAIRS, DEPARTMENT OF | ||||
Unlock the best of InstantMarkets.Please Sign In to see more out of InstantMarkets such as history, intelligent business alerts and many more.
Don't have an account yet? Create a free account now.
NEW AWARD FOR ATROPINE/DIPHENOXYLATE HCL TABLETS WITH SPECGX, LLC . PERIOD OF PERFORMANCE IS MAY 27, 2023 THROUGH MAY 26, 2024 WITH FOUR ONE YEAR OPTION YEARS. Solicitation ID/Procurement Identifier: 36E79723R0005 Ultimate Completion Date: Sun May 26 17:00:00 GMT
Location
Address: USA,
Country : United StatesYou may also like
NEW AWARD FOR EZETIMIBE TABLETS WITH MARLEX PHARMACEUTICALS. PERIOD OF PERFORMANCE IS APRIL 28, 2024 - APRIL 27, 2025 WITH FOUR ONE-YEAR OPTIONS
Due: 27 Apr, 2025 (in 12 months)MCKESSON CII-V PERIOD OF PERFORMANCE: 11/1/2020 THROUGH 11/30/2020 IN ACCORDANCE WITH VA CONTRACT #: 36W79720D0001 AND IAA 943
Due: 08 Aug, 2028 (in about 4 years)6505--Radiopharmaceuticals Base Plus Four Option Years VA New Mexico
Due: 07 Jun, 2024 (in 1 month)Please Sign In to see more like these.
Don't have an account yet? Create a free account now.